These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17619673)

  • 21. Optimal dose and timing of insulin Aspart to mimic first phase insulin response in patients with recently onset type 2 diabetes.
    Gredal C; Rosenfalck A; Dejgaard A; Hilsted J
    Diabetes Res Clin Pract; 2008 May; 80(2):293-8. PubMed ID: 18304675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study.
    Khutsoane D; Sharma SK; Almustafa M; Jang HC; Azar ST; Danciulescu R; Shestakova M; Ayad NM; Guler S; Bech OM;
    Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
    Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
    Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
    Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
    Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of new basal insulin analogues in the initiation and optimisation of insulin therapy in type 2 diabetes.
    Baxter MA
    Acta Diabetol; 2008 Dec; 45(4):253-68. PubMed ID: 18766296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensifying insulin therapy in patients with type 2 diabetes mellitus.
    Hirsch IB
    Am J Med; 2005 May; 118 Suppl 5A():21S-6S. PubMed ID: 15850550
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Step-wise drug therapy in type 2 diabetes mellitus].
    König K; Schatz H
    Z Arztl Fortbild Qualitatssich; 1998 Sep; 92(7):467-73. PubMed ID: 9842691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Basal insulin therapy strategy is superior to premixed insulin therapy in the perioperative period blood glucose management.
    Huang QX; Lou FC; Wang P; Liu Q; Wang K; Zhang L; Zhu L; Yu S; Xu H; Wang Q; Zhang Y; Hou WK
    Chin Med J (Engl); 2013 Nov; 126(21):4030-6. PubMed ID: 24229669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Type 2 diabetes - controlling hyperglycaemia with early insulin use.
    MacIsaac R; Cheung A; Jerums G
    Aust Fam Physician; 2010 Aug; 39(8):565-9. PubMed ID: 20877750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. U-500 insulin: why, when and how to use in clinical practice.
    Garg R; Johnston V; McNally PG; Davies MJ; Lawrence IG
    Diabetes Metab Res Rev; 2007 May; 23(4):265-8. PubMed ID: 17109474
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Diabetes mellitus in the elderly].
    van der Veen EA
    Tijdschr Gerontol Geriatr; 1990 Feb; 21(1):7-10. PubMed ID: 2180142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An RCT into calculating insulin start dose in type 2 diabetes.
    Jarvis J; Burden A; Burden ML
    Nurs Times; 2004 May 25-31; 100(21):40-4. PubMed ID: 15192923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rational choice of oral antihyperglycaemic agents.
    Chowdhury S; Sengupta N
    J Indian Med Assoc; 2002 Mar; 100(3):174-5, 177. PubMed ID: 12408278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
    [No Abstract]   [Full Text] [Related]  

  • 35. Options for intensification of basal insulin in type 2 diabetes: Premeal insulin or short-acting GLP-1 receptor agonists?
    Darmon P; Raccah D
    Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S21-6S27. PubMed ID: 26774016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intensifying treatment of type 2 diabetes mellitus: adding insulin.
    Peters KR
    Pharmacotherapy; 2011 Dec; 31(12 Suppl):54S-64S. PubMed ID: 22122223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Initiating and intensifying insulin therapy for type 2 diabetes: why, when, and how.
    Cobble ME
    Am J Ther; 2009; 16(1):56-64. PubMed ID: 19142156
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspectives in type 2 diabetes: incorporating the latest insulin analogue strategies to achieve treatment success.
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 5():iii-iv. PubMed ID: 19817775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Type 1 diabetes and prolonged fasting.
    Reiter J; Wexler ID; Shehadeh N; Tzur A; Zangen D
    Diabet Med; 2007 Apr; 24(4):436-9. PubMed ID: 17367310
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal initiation of insulin in type 2 diabetes.
    Hirsch IB; Vega CP
    MedGenMed; 2005 Nov; 7(4):49. PubMed ID: 16614671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.